Orthofix Medical Inc. Deferred Foreign Income Tax Expense (Benefit)
Orthofix Medical Inc. (OFIX) reported Deferred Foreign Income Tax Expense (Benefit) of -$550.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-24
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for the quarter ending 2016-12-31 was $1.16M.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for the quarter ending 2016-09-30 was $0.00.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for the quarter ending 2013-12-31 was -$1.18M.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for the quarter ending 2013-09-30 was $0.00.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$550.00K, a 276.85% decline from fiscal 2024.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was $311.00K.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$581.00K, a 335.22% decline from fiscal 2022.
- Orthofix Medical Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $247.00K, a 30.00% increase from fiscal 2021.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 3 month | Deferred Foreign Income Tax Expense (Benefit) 6 month | Deferred Foreign Income Tax Expense (Benefit) 9 month | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$550.00K 10-K · filed 2026-02-24 | ||||
| 2024-12-31 | $311.00K 10-K · filed 2026-02-24 | ||||
| 2023-12-31 | -$581.00K 10-K · filed 2026-02-24 | ||||
| 2022-12-31 | $247.00K 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $190.00K 10-K · filed 2024-03-05 | ||||
| 2020-12-31 | $10.82M 10-K · filed 2023-03-06 | ||||
| 2019-12-31 | -$615.00K 10-K · filed 2022-02-25 | ||||
| 2018-12-31 | $769.00K 10-K · filed 2021-02-26 | ||||
| 2017-12-31 | $1.20M 10-K · filed 2020-02-24 | ||||
| 2016-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $1.16M derived: sum of 2 quarters · filed 2019-02-25 | $1.16M 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $0.00 10-Q · filed 2016-10-31 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-01 | ||||
| 2015-12-31 | $1.54M 10-K · filed 2018-02-26 | ||||
| 2014-12-31 | -$9.88M 10-K · filed 2017-02-27 | ||||
| 2013-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$1.18M derived: sum of 2 quarters · filed 2016-02-29 | -$1.18M derived: sum of 3 quarters · filed 2016-02-29 | -$1.18M 10-K · filed 2016-02-29 | -$869.00K 10-K · filed 2014-03-31 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-25 | $0.00 derived: sum of 2 quarters · filed 2014-03-25 | $0.00 10-Q · filed 2014-03-25 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-03-24 | $0.00 10-Q · filed 2014-03-24 | |||
| 2013-03-31 | $0.00 10-Q/A · filed 2014-03-24 | ||||
| 2012-12-31 | $1.10M 10-K · filed 2015-04-29 | $346.00K 10-K · filed 2013-03-01 | |||
| 2011-12-31 | -$700.00K 10-K/A · filed 2015-03-31 | $1.10M 10-K · filed 2012-02-29 | |||
| 2010-12-31 | $2.16M 10-K/A · filed 2014-03-24 | $1.71M 10-K · filed 2012-02-29 | |||
| 2009-12-31 | $2.29M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |